IMR Press / CEOG / Volume 36 / Issue 2 / pii/1630635626169-2136633340

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Activity of telomerase in ovarian cancer cells. Clinical implications
Show Less
1 Department of Gynaecological Oncology, Poznan Univesity of Medical Sciences
2 Perinatology and Gynaecology Department of the Poznan Univesity of Medical, Sciences, Poznan (Poland)
Clin. Exp. Obstet. Gynecol. 2009, 36(2), 91–96;
Published: 10 June 2009
Abstract

Estimation of telomerase activity in cell nuclei of ovarian malignant tumours may provide an independent prognostic index. The test for telomerase activity in tumour cell nuclei may be accepted as a useful diagnostic test with application for differential diagnoses of benign ovarian tumours vs tumours of a borderline or malignant character.
Keywords
Ovarian cancer
Telomerase
Telomeres
Share
Back to top